Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 049597/0387 | |
| Pages: | 5 |
| | Recorded: | 06/26/2019 | | |
Attorney Dkt #: | MYZ_19056US |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16473888
|
Filing Dt:
|
06/26/2019
|
Publication #:
|
|
Pub Dt:
|
11/07/2019
| | | | |
Title:
|
Combination drug suitable for treatment and prevention of non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration
|
|
Assignee
|
|
|
A2-412, 1-22, YAMADANISHI, SUITA-SHI |
OSAKA, JAPAN 565-0824 |
|
Correspondence name and address
|
|
IP BUSINESS SOLUTIONS, LLC
|
|
P.O. BOX 527
|
|
ARLINGTON, VA 22216
|
Search Results as of:
04/27/2024 05:20 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|